Thursday, October 24, 2019
Medical News Today: Failed dementia drug gets a second chance
Biotech company Biogen have announced that they will file for official approval of a new Alzheimer's drug, while results in clinical trials were uncertain.
Related Posts:
With 'low confidence,' Energy Dept. says Covid-19 likely from lab; FBI confidence 'moderate;' intel panel, 4 other agencies disagree
School officials sound the alarm about students getting sick from vaping and the threat of illegal or deadly substances in devices
Covid-19 risk remains low in most counties; only four estimated to have high risk; Kentucky's 7-day infection rate is 16th in the nation
American Heart Month and Black History Month are the same month, and are related; Blacks are likelier have heart disease
Bill to ban transgender health or mental-health care of minors in Kentucky has a head of steam in the state House
0 comments:
Post a Comment